← Scroll for more →
Nkarta, Inc. (NKTX)
Pharmaceutical Preparations
Latest Price
$1.56
TTM P/E
--
Normalized P/E
--
TTM Div Yield
--
Fwd Div Yield
--
Book Value
3.46
P/B Ratio
0.45
Institutional Ownership
77.8% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| RA Capital Management, L.P. | 10.81M | $30.0M | 14.53% | -- | 2026-06-30 |
| BlackRock, Inc. | 6.30M | $17.0M | 8.47% | +1.79M | 2026-06-30 |
| NEA Management Company, LLC | 3.57M | $10.0M | 4.80% | -- | 2026-06-30 |
| Samsara Biocapital, LLC | 3.51M | $9.0M | 4.72% | -- | 2026-06-30 |
| SR One Capital Management, LP | 3.33M | $9.0M | 4.48% | -- | 2026-06-30 |
| GSK plc | 3.15M | $8.0M | 4.24% | -- | 2026-06-30 |
| Monaco Asset Management SAM | 2.37M | $6.0M | 3.19% | -148.5K | 2026-06-30 |
| Citadel Advisors LLC | 2.26M | $6.0M | 3.03% | +450.7K | 2026-06-30 |
| Vanguard Capital Management LLC | 2.23M | $6.0M | 2.99% | +215.0K | 2026-06-30 |
| Two Sigma Investments, LP | 1.87M | $5.0M | 2.52% | -- | 2026-06-30 |